Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials - PubMed (original) (raw)
Meta-Analysis
doi: 10.3945/ajcn.111.023457. Epub 2012 Feb 1.
Affiliations
- PMID: 22301923
- DOI: 10.3945/ajcn.111.023457
Free article
Meta-Analysis
Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials
Lee Hooper et al. Am J Clin Nutr. 2012 Mar.
Free article
Abstract
Background: There is substantial interest in chocolate and flavan-3-ols for the prevention of cardiovascular disease (CVD).
Objective: The objective was to systematically review the effects of chocolate, cocoa, and flavan-3-ols on major CVD risk factors.
Design: We searched Medline, EMBASE, and Cochrane databases for randomized controlled trials (RCTs) of chocolate, cocoa, or flavan-3-ols. We contacted authors for additional data and conducted duplicate assessment of study inclusion, data extraction, validity, and random-effects meta-analyses.
Results: We included 42 acute or short-term chronic (≤18 wk) RCTs that comprised 1297 participants. Insulin resistance (HOMA-IR: -0.67; 95% CI: -0.98, -0.36) was improved by chocolate or cocoa due to significant reductions in serum insulin. Flow-mediated dilatation (FMD) improved after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intakes. Effects on HOMA-IR and FMD remained stable to sensitivity analyses. We observed reductions in diastolic blood pressure (BP; -1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg) and marginally significant effects on LDL (-0.07 mmol/L; 95% CI: -0.13, 0.00 mmol/L) and HDL (0.03 mmol/L; 95% CI: 0.00, 0.06 mmol/L) cholesterol. Chocolate or cocoa improved FMD regardless of the dose consumed, whereas doses >50 mg epicatechin/d resulted in greater effects on systolic and diastolic BP. GRADE (Grading of Recommendations, Assessment, Development and Evaluation, a tool to assess quality of evidence and strength of recommendations) suggested low- to moderate-quality evidence of beneficial effects, with no suggestion of negative effects. The strength of evidence was lowered due to unclear reporting for allocation concealment, dropouts, missing data on outcomes, and heterogeneity in biomarker results in some studies.
Conclusions: We found consistent acute and chronic benefits of chocolate or cocoa on FMD and previously unreported promising effects on insulin and HOMA-IR. Larger, longer-duration, and independently funded trials are required to confirm the potential cardiovascular benefits of cocoa flavan-3-ols.
Similar articles
- Effect of cocoa on blood pressure.
Ried K, Fakler P, Stocks NP. Ried K, et al. Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD008893. doi: 10.1002/14651858.CD008893.pub3. Cochrane Database Syst Rev. 2017. PMID: 28439881 Free PMC article. - Effect of cocoa on blood pressure.
Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. Ried K, et al. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008893. doi: 10.1002/14651858.CD008893.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895979 Updated. - Altered dietary salt intake for preventing diabetic kidney disease and its progression.
Hodson EM, Cooper TE. Hodson EM, et al. Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3. Cochrane Database Syst Rev. 2023. PMID: 36645291 Free PMC article. - Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ, Barnard S, Perel P, Free C. Palmer MJ, et al. Cochrane Database Syst Rev. 2018 Jun 22;6(6):CD012675. doi: 10.1002/14651858.CD012675.pub2. Cochrane Database Syst Rev. 2018. PMID: 29932455 Free PMC article. Updated. - Dietary fibre for the primary prevention of cardiovascular disease.
Hartley L, May MD, Loveman E, Colquitt JL, Rees K. Hartley L, et al. Cochrane Database Syst Rev. 2016 Jan 7;2016(1):CD011472. doi: 10.1002/14651858.CD011472.pub2. Cochrane Database Syst Rev. 2016. PMID: 26758499 Free PMC article.
Cited by
- Polyphenols, inflammation, and cardiovascular disease.
Tangney CC, Rasmussen HE. Tangney CC, et al. Curr Atheroscler Rep. 2013 May;15(5):324. doi: 10.1007/s11883-013-0324-x. Curr Atheroscler Rep. 2013. PMID: 23512608 Free PMC article. Review. - Immunomodulatory Effects of Dietary Polyphenols.
Shakoor H, Feehan J, Apostolopoulos V, Platat C, Al Dhaheri AS, Ali HI, Ismail LC, Bosevski M, Stojanovska L. Shakoor H, et al. Nutrients. 2021 Feb 25;13(3):728. doi: 10.3390/nu13030728. Nutrients. 2021. PMID: 33668814 Free PMC article. Review. - Dietary flavonoid intake and cardiovascular risk: a population-based cohort study.
Ponzo V, Goitre I, Fadda M, Gambino R, De Francesco A, Soldati L, Gentile L, Magistroni P, Cassader M, Bo S. Ponzo V, et al. J Transl Med. 2015 Jul 8;13:218. doi: 10.1186/s12967-015-0573-2. J Transl Med. 2015. PMID: 26152229 Free PMC article. - Improving the estimation of flavonoid intake for study of health outcomes.
Peterson JJ, Dwyer JT, Jacques PF, McCullough ML. Peterson JJ, et al. Nutr Rev. 2015 Aug;73(8):553-76. doi: 10.1093/nutrit/nuv008. Epub 2015 Jun 16. Nutr Rev. 2015. PMID: 26084477 Free PMC article. - Chocolate and health-related quality of life: a prospective study.
Balboa-Castillo T, López-García E, León-Muñoz LM, Pérez-Tasigchana RF, Banegas JR, Rodríguez-Artalejo F, Guallar-Castillón P. Balboa-Castillo T, et al. PLoS One. 2015 Apr 22;10(4):e0123161. doi: 10.1371/journal.pone.0123161. eCollection 2015. PLoS One. 2015. PMID: 25901348 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources